Project Full Title: AcceleRating the Translation of virtual twins towards a pErsonalised Management of steatotic liver patients
Project acronym: ARTEMIs
Project type: Horizon Europe | RIA (Topic HORIZON-HLTH-2023-TOOL-05-03)
Grant agreement no: 101136299
The global objective of ARTEMIs Project is the development and the Proof of Concept evaluation of a clinical decision support system (CDSS) for application in the clinical management of metabolic dysfunction-associated steatotic liver disease (MASLD is the new nomenclature, previously MAFLD). The CDSS is aimed to provide clinically meaningful information to clinicians, for a more personalised management of MASLD patients.
The aim of this deliverable is to define the plan for the development of the exploitation strategy for the ARTEMIs CDSS. This deliverable will define the roadmap to be followed by tasks 9.1 – IPR management and 9.2 – Exploitation planning for novel tools and methodologies as part of WP9 – Exploitation and Sustainability, with the goal of promoting and accelerating the commercial uptake of the ARTEMIs project results.
This plan will define an exploitation strategy coherent with Horizon Europe beneficiaries’ obligation to make their best efforts to exploit the project results.
